Prizes & Recognitions
Our Journey of Success and Recognition
Our work directly supports the development of cancer vaccines and T-cell therapies. We sit at the intersection of mass spectrometry, immunopeptidomics, and machine learning — with a team of 15 making global impact.
Our HLA-Compass database contains 1.4 million unique peptides from over 4,160 samples, serving researchers at leading pharma and biotech companies worldwide.
Award-winning team: KI Champions BW 2025 · Innovationspreis Freiburg 2025 · de:hub AI Award Finalist · Women TechEU Award · CyberChampion 2024
Alithea Bio Wins Two VivaTech 2026 Awards
Following the German Innovation Award, Alithea Bio went on to win two prestigious awards at VivaTech 2026 in Paris — Europe’s largest tech and innovation event with over 200,000 attendees.
Alithea Bio took home the Tech for Change Award in the Health category, recognising HLA-Compass as a breakthrough AI platform accelerating safer cancer immunotherapy development. The company also won the Audience Award — voted by the global tech community as the most impactful startup at the exhibition.
Two awards. One mission: making cancer immunotherapy faster, safer, and more precise — powered by 22 million real human tissue data points.
Alithea Bio – CyberChampion 2024
Alithea Bio won the prestigious CyberChampion 2024 award, receiving €10,000 and 6 months of communication mentoring from Nacona Academy. Their innovative solution, aiming to transform cancer immunotherapies, impressed the jury and celebrated the startup’s impact in the tech community.
Discover More
Alithea Bio – de:hub AI Award 2025 Finalist
Alithea Bio was selected as one of four finalists for the German-wide de:hub AI Award 2025 by BMWK, recognized for its innovative end-to-end cancer immunotherapy platform, HLA-Compass. The nomination highlights the startup’s leadership in AI-driven healthcare solutions.
Discover More
Fanny Giannou – European Prize for Women Innovators 2025 Semi-Finalist
Fanny Giannou was selected as a semi-finalist for the 2025 European Prize for Women Innovators, recognized for her pioneering work in precision immunotherapy and AI-driven cancer drug development. This honor celebrates her impact as a leading female innovator shaping the future of healthcare.
Discover More
Alithea Bio – KI Champions Baden-Württemberg 2025
Alithea Bio was honored as a KI Champion 2025, recognized for its innovation and leadership in AI-driven healthcare solutions. The award highlights the startup’s excellence among 56 applicants in Baden-Württemberg’s prestigious AI competition.
Discover More
Alithea Bio – Innovationspreis Freiburg 2025
Alithea Bio won the Freiburger Innovationspreis 2025 for its HLA‑Compass platform, a SaaS solution using AI and ultra-sensitive mass spectrometry to identify critical HLA peptides. The platform accelerates and refines personalized immunotherapy, advancing cancer research and digital twin applications.
Discover More
Alithea Bio – R&D Seal (FuE-Siegel) Recipient
Alithea Bio has been awarded the German R&D Seal (FuE-Siegel) for excellence in research and development, recognizing scientific novelty, technical complexity, and structured project planning. This milestone affirms the company’s leadership in precision immunotherapy and innovation in biotech.
Discover More
Leading the Future of Precision Immunotherapy
Alithea Bio: Pioneering HLA peptide Characterization with Innovative Immunopeptidomics, highly sensitive Mass Spectrometry and applied AI
